Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen L Atkin

Showing results (41-50 of 378) with videos related to

Pageof 38
Sort By:
Diabetes Care|August 28, 2010
The role of blood pressure variability in the development of nephropathy in type 1 diabetesEric S Kilpatrick, Alan S Rigby, Stephen L Atkin
Journal of Cellular Physiology|November 13, 2018
A review of the anti-inflammatory properties of antidiabetic agents providing protective effects against vascular complications in diabetesHabib Yaribeygi, Stephen L Atkin, Matteo Pirro, et al.
Frontiers in Endocrinology|March 13, 2018
Effects of Growth Hormone Replacement on Peripheral Muscle and Exercise Capacity in Severe Growth Hormone DeficiencySusana Gonzalez, Thozhukat Sathyapalan, Zeeshan Javed, et al.
Clinical Chemistry|March 27, 2007
Variability in the relationship between mean plasma glucose and HbA1c: implications for the assessment of glycemic controlEric S Kilpatrick, Alan S Rigby, Stephen L Atkin
Diabetes Care|March 1, 2007
Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes" in the Diabetes Control and Complications TrialEric S Kilpatrick, Alan S Rigby, Stephen L Atkin
International Immunopharmacology|May 2, 2023
Identification of key upregulated genes involved in foam cell formation and the modulatory role of statin therapyAli Mahmoudi, Stephen L Atkin, Tannaz Jamialahmadi, et al.
Pharmacological Research|January 15, 2019
Current evidence and future perspectives for curcumin and its analogues as promising adjuncts to oxaliplatin: state-of-the-artMahtab Zangui, Stephen L Atkin, Muhammed Majeed, et al.
Diabetes & Metabolic Syndrome|August 14, 2019
Effects of newly introduced antidiabetic drugs on autophagyMilad Ashrafizadeh, Habib Yaribeygi, Stephen L Atkin, et al.
Glycoconjugate Journal|October 14, 2025
The effects of DPP4 inhibitors, SGLT2 inhibitors and GLP1-RA on the AGE/RAGE pathway: implications for diabetes and its complicationsSajad Abolfazli, Stephen L Atkin, Tannaz Jamialahmadi, et al.
Journal of Cellular Physiology|November 15, 2018
A review of the molecular pathways mediating the improvement in diabetes mellitus following caloric restrictionHabib Yaribeygi, Stephen L Atkin, Majid Ramezani, et al.
Pageof 38

Showing results (41-50 of 378) with videos related to

Sort By:
Pageof 38
Diabetes Care|August 28, 2010
The role of blood pressure variability in the development of nephropathy in type 1 diabetesEric S Kilpatrick, Alan S Rigby, Stephen L Atkin
Journal of Cellular Physiology|November 13, 2018
A review of the anti-inflammatory properties of antidiabetic agents providing protective effects against vascular complications in diabetesHabib Yaribeygi, Stephen L Atkin, Matteo Pirro, et al.
Frontiers in Endocrinology|March 13, 2018
Effects of Growth Hormone Replacement on Peripheral Muscle and Exercise Capacity in Severe Growth Hormone DeficiencySusana Gonzalez, Thozhukat Sathyapalan, Zeeshan Javed, et al.
Clinical Chemistry|March 27, 2007
Variability in the relationship between mean plasma glucose and HbA1c: implications for the assessment of glycemic controlEric S Kilpatrick, Alan S Rigby, Stephen L Atkin
Diabetes Care|March 1, 2007
Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes" in the Diabetes Control and Complications TrialEric S Kilpatrick, Alan S Rigby, Stephen L Atkin
International Immunopharmacology|May 2, 2023
Identification of key upregulated genes involved in foam cell formation and the modulatory role of statin therapyAli Mahmoudi, Stephen L Atkin, Tannaz Jamialahmadi, et al.
Pharmacological Research|January 15, 2019
Current evidence and future perspectives for curcumin and its analogues as promising adjuncts to oxaliplatin: state-of-the-artMahtab Zangui, Stephen L Atkin, Muhammed Majeed, et al.
Diabetes & Metabolic Syndrome|August 14, 2019
Effects of newly introduced antidiabetic drugs on autophagyMilad Ashrafizadeh, Habib Yaribeygi, Stephen L Atkin, et al.
Glycoconjugate Journal|October 14, 2025
The effects of DPP4 inhibitors, SGLT2 inhibitors and GLP1-RA on the AGE/RAGE pathway: implications for diabetes and its complicationsSajad Abolfazli, Stephen L Atkin, Tannaz Jamialahmadi, et al.
Journal of Cellular Physiology|November 15, 2018
A review of the molecular pathways mediating the improvement in diabetes mellitus following caloric restrictionHabib Yaribeygi, Stephen L Atkin, Majid Ramezani, et al.
Pageof 38